The DOI matches its Crossref record; 12 of the 13 references it cites were found in a registry or an index.
Antibody Responses to SARS-CoV-2 in Patients With Novel Coronavirus Disease 2019
Open accessPublished version of a preprint
Abstract
Background: The novel coronavirus SARS-CoV-2 is a newly emerging virus. The antibody response in infected patients remains largely unknown, and the clinical value of antibody testing has not been fully demonstrated. Methods: 173 patients with SARS-CoV-2 infection were enrolled. Their serial plasma samples (n = 535) collected during hospitalization were tested for total antibodies (Ab), IgM, and IgG against SARS-CoV-2. The dynamics of antibodies with disease progress were analyzed. Results: Among 173 patients, the seroconversion rates for Ab, IgM, and IgG were 93.1%, 82.7%, and 64.7%, respectively. The reason for the negative antibody findings in 12 patients might be due to the lack of blood samples at the later stage of illness. The median seroconversion times for Ab, IgM, and then IgG were days 11, 12, and 4, respectively. The presence of antibodies was <40% among patients within 1 week of onset, and rapidly increased to 100.0% (Ab), 94.3% (IgM), and 79.8% (IgG) by day 15 after onset. In contrast, RNA detectability decreased from 66.7% (58/87) in samples collected before day 7 to 45.5% (25/55) during days 15–39. Combining RNA and antibody detection significantly improved the sensitivity of pathogenic diagnosis for COVID-19 (P < .001), even in the early phase of 1 week from onset (P = .007). Moreover, a higher titer of Ab was independently associated with a worse clinical classification (P = .006). Conclusions: Antibody detection offers vital clinical information during the course of SARS-CoV-2 infection. The findings provide strong empirical support for the routine application of serological testing in the diagnosis and management of COVID-19 patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“We aligned cases and seroprevalence on the basis of individual record data suggesting that exposure to a laboratory-confirmed case was typically 10–13 days36 and exposure to seroconversion was 14–17 days.37, 38, 39”
From Estimating global, regional, and national daily and cumulative infections with SARS-CoV-2 through Nov 14, 2021: a statistical analysis (2022) · cites this paper as [37]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., Zhang, L., Fan, G., Xu, J., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30183-5 · Cited by 48,884
Self-citationClinical characteristics of coronavirus disease 2019 in China
Guan, W.-J., Ni, Z.-Y., Hu, Y., Liang, W.-H., Ou, C.-Q., He, J.-X., Liu, L., Shan, H., Lei, C.-L., Hui, D. S. C., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2002032 · Cited by 30,246
Self-citationChen, N., Zhou, M., Dong, X., Qu, J., Gong, F., Han, Y., Qiu, Y., Wang, J., Liu, Y., Wei, Y., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30211-7 · Cited by 21,415
Self-citationWang, D., Hu, B., Hu, C., Zhu, F., Liu, X., Zhang, J., Wang, B., Xiang, H., Cheng, Z., Xiong, Y., et al. (2020) · JAMA · doi:10.1001/jama.2020.1585 · Cited by 20,148
Self-citationLa certeza de lo impredecible: Cultura Educación y Sociedad en tiempos de COVID19
Martínez González, M. (2020) · DSPACE System - Metalibrary (University of the Coast) · Cited by 18,463
Chan, J., Yuan, S.-F., Kok, K.-H., To, K., Chu, H., Yang, J., Xing, F., Liu, J.-L., Yip, C., Poon, R., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30154-9 · Cited by 8,450
SARS-CoV-2 Viral Load in Upper Respiratory Specimens of Infected Patients
Zou, L., Ruan, F., Huang, M.-X., Liang, L.-J., Huang, H., Hong, Z.-S., Yu, J.-X., Kang, M., Song, Y.-C., Xia, J., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmc2001737 · Cited by 4,590
Peiris, J., Chu, C., Cheng, V., Chan, K., Hung, I., Poon, L., Law, K., Tang, B., Hon, T., Chan, C., et al. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13412-5 · Cited by 2,375
Yang, Y., Yang, M., Shen, C., Wang, F., Yuan, J., Li, J., Zhang, M., Wang, Z., Xing, L., Wei, J., et al. (2020) · doi:10.1101/2020.02.11.20021493 · Cited by 836
Self-citationLiu, L., Wei, Q., Lin, Q., Fang, J., Wang, H., Kwok, H., Tang, H., Nishiura, K., Peng, J., Tan, Z., et al. (2019) · JCI Insight · doi:10.1172/jci.insight.123158 · Cited by 830
Self-citation
Research works printed but not linked: 1
- Guan, Cli, N Engl J Med
Cited by
Sorted by citations
Items 801–900 of 1,003
SARS-CoV-2 serology: Test, test, test, but interpret with caution!
Bermingham, W. H., Wilding, T., Beck, S. C., & Huissoon, A. P. (2020) · Clinical Medicine · doi:10.7861/clinmed.2020-0170 · Cited by 27
Shaw, A. M., Hyde, C., Merrick, B., James‐Pemberton, P. H., Squires, B. K., Olkhov, R. V., Batra, R., Patel, A., Bisnauthsing, K. N., Nebbia, G., et al. (2020) · The Analyst · doi:10.1039/d0an01066a · Cited by 27
The Spectrum of Clinical and Serological Features of COVID-19 in Urban Hemodialysis Patients
da Cunha, T. S., Gomá-Garcés, E., Avello, A., Pereira, M., Mas, S., Ortíz, A., & González‐Parra, E. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9072264 · Cited by 26
Schön, M. P., Berking, C., Biedermann, T., Buhl, T., Erpenbeck, L., Eyerich, K., Eyerich, S., Ghoreschi, K., Goebeler, M., Ludwig, R. J., et al. (2020) · JDDG Journal der Deutschen Dermatologischen Gesellschaft · doi:10.1111/ddg.14169_g · Cited by 28
A guide to laboratory diagnosis of Corona Virus Disease-19 for the gastroenterologists
Ghoshal, U., Vasanth, S., & Tejan, N. (2020) · Indian Journal of Gastroenterology · doi:10.1007/s12664-020-01082-3 · Cited by 27
Barzin, A., Schmitz, J. L., Rosin, S. P., Sirpal, R., Almond, M. A., Robinette, C., Wells, S., Hudgens, M. G., Olshan, A. F., Deen, S., et al. (2020) · mBio · doi:10.1128/mbio.02426-20 · Cited by 25
Reinfection of COVID-19 in Pakistan: A First Case Report
Hanif, M., Haider, M. A., Ali, M. J., Naz, S., & Sundas, F. (2020) · Cureus · doi:10.7759/cureus.11176 · Cited by 25
Lin, Y., Cai, B., Li, Y., Wang, M., An, Y., Deng, R., Li, D., Wang, L., Xu, H., Gao, X., et al. (2020) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.16044 · Cited by 27
Law, J. C., Koh, W. H., Budylowski, P., Lin, J., Yue, F., Abe, K. T., Rathod, B., Girard, M., Li, Z., Rini, J. M., et al. (2020) · The Journal of Immunology · doi:10.4049/jimmunol.2001067 · Cited by 27
Self-citationSkittrall, J. P., Fortune, M. D., Jalal, H., Zhang, H., Enoch, D., Brown, N. M., & Swift, A. (2021) · The Lancet Regional Health - Europe · doi:10.1016/j.lanepe.2020.100002 · Cited by 27
A review on the effect of COVID-19 in type 2 asthma and its management
Ghosh, S., Das, S., Mondal, R., Abdullah, S., Sultana, S., Singh, S., Sehgal, A., & Behl, T. (2020) · International Immunopharmacology · doi:10.1016/j.intimp.2020.107309 · Cited by 27
Prakash, O., Solanki, B., Sheth, J. K., Joshi, B., Kadam, M., Vyas, S., Shukla, A. A., Tiwari, H., Rathod, S., Rajput, A., et al. (2021) · BMJ Open · doi:10.1136/bmjopen-2020-044101 · Cited by 27
Do not neglect SARS-CoV-2 hospitalization and fatality risks in the middle-aged adult population
Lapidus, N., Paireau, J., Lévy-Bruhl, D., de Lamballerie, X. N., Severi, G., Touvier, M., Zins, M., Cauchemez, S., Carrat, F., & the SAPRIS-SERO study group (2020) · Infectious Diseases Now · doi:10.1016/j.idnow.2020.12.007 · Cited by 27
Kutsuna, S., Asai, Y., Matsunaga, A., Kinoshita, N., Terada, M., Miyazato, Y., Nakamoto, T., Suzuki, T., Saito, S., Endo, M., et al. (2021) · Journal of Infection and Chemotherapy · doi:10.1016/j.jiac.2021.01.006 · Cited by 27
Big data driven COVID-19 pandemic crisis management: Potential approach for global health
Lv, Y., Ma, C., Li, X., & Wu, M. (2021) · Archives of Medical Science · doi:10.5114/aoms/133522 · Cited by 28
Luo, Y. R., Yun, C., Chakraborty, I., Wu, A. H. B., & Lynch, K. L. (2021) · Journal of Clinical Microbiology · doi:10.1128/jcm.00193-21 · Cited by 24
Age, Disease Severity and Ethnicity Influence Humoral Responses in a Multi-Ethnic COVID-19 Cohort
Smith, M., Abdesselem, H., Mullins, M. O., Tan, T.-M., Nel, A. J. M., Al‐Nesf, M. A., Bensmail, I., Majbour, N. K., Vaikath, N. N., Naik, A., et al. (2021) · Viruses · doi:10.3390/v13050786 · Cited by 27
Analytical Performance of COVID-19 Detection Methods (RT-PCR): Scientific and Societal Concerns
Verna, R., Alallón, W., Murakami, M., Hayward, C. P. M., Harrath, A. H., Alwasel, S. H., Sumita, N. M., Alataş, Ö., Fedeli, V., Sharma, P., et al. (2021) · Life · doi:10.3390/life11070660 · Cited by 28
Shurrab, F. M., Younes, N., Al‐Sadeq, D. W., Liu, N., Qotba, H. A., Abu-Raddad, L. J., & Nasrallah, G. K. (2022) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2022.02.052 · Cited by 27
Nanoplasmonic multiplex biosensing for COVID-19 vaccines
Funari, R., Fukuyama, H., & Shen, A. Q. (2022) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2022.114193 · Cited by 27
Seroprevalence of SARS-CoV-2 Antibodies in Africa: A Systematic Review and Meta-Analysis
Hajissa, K., Islam, M. A., Hassan, S. A., Zaidah, A. R., Ismail, N., & Mohamed, Z. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph19127257 · Cited by 28
Zlei, M., Sidorov, I. A., Joosten, S. A., Heemskerk, M. H. M., Myeni, S. K., Pothast, C. R., Brouwer, C. S. V. D. B.-D., van der Zanden, A. L., van Meijgaarden, K. E., Morales, S. T., et al. (2022) · Cells · doi:10.3390/cells11172743 · Cited by 30
Rump, A., Risti, R., Kristal, M.-L., Reut, J., Syritski, V., Lõokene, A., & Boudinot, S. R. (2020) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2020.11.060 · Cited by 27
Qian, J., Xia, J., Chiang, S. H., Liu, J. F., Li, K., Li, F., Wei, F., Aziz, M. A., Kim, Y., Go, V., et al. (2025) · Science Advances · doi:10.1126/sciadv.adt5464 · Cited by 27
3D-Printed Splitter for Use of a Single Ventilator on Multiple Patients During COVID-19
Ayyıldız, S., Dursun, A. M., Yıldırım, V., İnce, M., Gülçelik, M. A., & Erdöl, C. (2020) · 3D Printing and Additive Manufacturing · doi:10.1089/3dp.2020.0102 · Cited by 26
Emerging Human Coronavirus Infections (SARS, MERS, and COVID-19): Where They Are Leading Us
Kumar, V. (2020) · International Reviews of Immunology · doi:10.1080/08830185.2020.1800688 · Cited by 29
SARS-CoV-2 seroprevalence in a Belgian cohort of patients with cystic fibrosis
Berardis, S., Verroken, A., Vetillart, A., Struyf, C., Gilbert, M., Gruson, D., & Gohy, S. (2020) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2020.08.005 · Cited by 24
Wan, Y., Li, Z., Wang, K., Tian, L., & Liao, P. (2020) · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · doi:10.1177/0004563220963847 · Cited by 26
Self-citationImmune Correlates of COVID-19 Control
Poonia, B., & Kottilil, S. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.569611 · Cited by 26
Cameron, A., Porterfield, C. A., Byron, L. D., Wang, J., Pearson, Z., Bohrhunter, J. L., Cardillo, A. B., Ryan-Muntz, L., Sorensen, R. A., Caserta, M. T., et al. (2020) · Journal of Clinical Microbiology · doi:10.1128/jcm.02489-20 · Cited by 27
Chirathaworn, C., Sripramote, M., Chalongviriyalert, P., Jirajariyavej, S., Kiatpanabhikul, P., Saiyarin, J., Soudon, C., Thienfaidee, O., Ayuthaya, T. P. N., Brukesawan, C., et al. (2020) · PLoS ONE · doi:10.1371/journal.pone.0236905 · Cited by 28
Multicenter registry of United States emergency department patients tested for SARS‐CoV‐2
Kline, J. A., Pettit, K. L., Kabrhel, C., Courtney, D. M., Nordenholz, K. E., & Camargo, C. A. (2020) · Journal of the American College of Emergency Physicians Open · doi:10.1002/emp2.12313 · Cited by 26
Current advances in the detection of COVID-19 and evaluation of the humoral response
Huergo, M. A., & Thanh, N. T. K. (2020) · The Analyst · doi:10.1039/d0an01686a · Cited by 27
How to Understand Herd Immunity in the Context of COVID-19
Dong, M., He, F., & Deng, Y. (2020) · Viral Immunology · doi:10.1089/vim.2020.0195 · Cited by 30
Insights into SARS-CoV-2 evolution, potential antivirals, and vaccines
Abdel-Moneim, A. S., Abdelwhab, E. M., & Memish, Z. A. (2021) · Virology · doi:10.1016/j.virol.2021.02.007 · Cited by 27
Zhang, Y. V., Wiencek, J. R., Meng, Q. H., Theel, E. S., Babić, N., Sepiashvili, L., Pecora, N., Slev, P. R., Cameron, A., & Konforte, D. (2021) · Clinical Chemistry · doi:10.1093/clinchem/hvab051 · Cited by 27
Immune response to SARS‐CoV‐2 in children: A review of the current knowledge
Filippatos, F., Tatsi, E., & Michos, A. G. (2021) · Pediatric Investigation · doi:10.1002/ped4.12283 · Cited by 26
Modeling serological testing to inform relaxation of social distancing for COVID-19 control
Kraay, A. N. M., Nelson, K., Zhao, C., Demory, D., Weitz, J. S., & Lopman, B. A. (2021) · Nature Communications · doi:10.1038/s41467-021-26774-y · Cited by 27
Rapid test to assess the escape of SARS-CoV-2 variants of concern
Heggestad, J. T., Britton, R. J., Kinnamon, D., Wall, S. A., Joh, D. Y., Hucknall, A., Olson, L. B., Anderson, J. G., Mazur, A., Wolfe, C. R., et al. (2021) · Science Advances · doi:10.1126/sciadv.abl7682 · Cited by 25
From Immunogen to COVID-19 vaccines: Prospects for the post-pandemic era
Miao, G., Chen, Z., Cao, H., Wu, W., Chu, X., Liu, H., Zhang, L., Zhu, H., Cai, H., Lu, X., et al. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.114208 · Cited by 27
Self-citationEzzikouri, S., Nourlil, J., Benjelloun, S., Kohara, M., & Tsukiyama–Kohara, K. (2020) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2020.1787068 · Cited by 26
collaborative, C., Hamilton, N., Jacob, T., Schilder, A. G., Arora, A., George, M., Green, F., Jackson, E., Goulder, J., Kumar, N., et al. (2020) · medRxiv · doi:10.1101/2020.05.22.20104679 · Cited by 26
Preoperative SARS-CoV-2 screening: Can it really rule out COVID-19?
Lother, S. (2020) · Canadian Journal of Anesthesia/Journal canadien d anesthésie · doi:10.1007/s12630-020-01746-w · Cited by 26
Management of non traumatic surgical emergencies during the COVID-19 pandemia
Parreira, J. G., Campos, T. D., LUCARELLI-ANTUNES, P. D. S., Perlingeiro, J. A. G., & Assef, J. C. (2020) · Revista do Colégio Brasileiro de Cirurgiões · doi:10.1590/0100-6991e-20202614 · Cited by 25
Kertes, J., Gez, S. B., Saciuk, Y., Supino‐Rosin, L., Shamir-Stein, N., Mizrahi-Reuveni, M., & Zohar, A. E. (2021) · Emerging infectious diseases · doi:10.3201/eid2802.211834 · Cited by 32
Abboud, H., Zheng, C. Y., Kar, I., Chen, C. K., Sau, C., & Serra, A. (2020) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2020.102249 · Cited by 25
Evaluation of eleven rapid tests for detection of antibodies against SARS-CoV-2
Tollånes, M. C., Kran, A. B., Abildsnes, E., Jenum, P. A., Breivik, A. C., & Sandberg, S. (2020) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2020-0628 · Cited by 25
Potential biomarkers predictors of mortality in COVID-19 patients in the Emergency Department
Gómez, N. F. P., Lobo, I. M., Granero‐Cremades, I., Tejerina, A. F., Rueda, F. R., Teleki, A. V. W., Campos, F. M. A., & Benito, M. Á. S. D. (2020) · Revista Española de Quimioterapia · doi:10.37201/req/060.2020 · Cited by 25
Infection with SARS-CoV-2 in primary care health care workers assessed by antibody testing
Lackermair, K., William, F., Grzanna, N., Lehmann, E., Fichtner, S., Kucher, H. B., Wilhelm, K., & Estner, H. (2020) · Family Practice · doi:10.1093/fampra/cmaa078 · Cited by 26
Diagnosis of COVID-19: facts and challenges
Zalzala, H. H. (2020) · New Microbes and New Infections · doi:10.1016/j.nmni.2020.100761 · Cited by 28
Ching, W. Y., Adhikari, P., Jawad, B., & Podgornik, R. (2021) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2021.02.004 · Cited by 24
Early detection of neutralizing antibodies against SARS-CoV-2 in COVID-19 patients in Thailand
Putcharoen, O., Wacharapluesadee, S., Chia, W. N., Paitoonpong, L., Tan, C. W., Suwanpimolkul, G., Jantarabenjakul, W., Ruchisrisarod, C., Wanthong, P., Sophonphan, J., et al. (2021) · PLoS ONE · doi:10.1371/journal.pone.0246864 · Cited by 25
Cell therapy strategies for COVID-19: Current approaches and potential applications
Zaki, M. M., Lesha, E., Said, K., Kiaee, K., Robinson‐McCarthy, L. R., George, H., Hanna, A., Appleton, E., Liu, S., Ng, A. H. M., et al. (2021) · Science Advances · doi:10.1126/sciadv.abg5995 · Cited by 25
Evaluation of Three Quantitative Anti-SARS-CoV-2 Antibody Immunoassays
Chapuy‐Regaud, S., Miédougé, M., Abravanel, F., Da-Silva, I., Porcheron, M., Fillaux, J., Dimeglio, C., & Izopet, J. (2021) · Microbiology Spectrum · doi:10.1128/spectrum.01376-21 · Cited by 26
COVID-19 and gut immunomodulation
Roy, K., Agarwal, S., Banerjee, R., Paul, M. K., & Purbey, P. K. (2021) · World Journal of Gastroenterology · doi:10.3748/wjg.v27.i46.7925 · Cited by 26
Gupta, S., Agrawal, S., Sandoval, A., Su, H., Tran, M., & Demirdağ, Y. Y. (2022) · Journal of Clinical Immunology · doi:10.1007/s10875-022-01256-y · Cited by 25
Wang, M., Song, J., Sun, J., Du, Y., Qin, X., Xia, L., Wu, Y., & Zhang, G. (2022) · Viruses · doi:10.3390/v14102170 · Cited by 25
Kinetics of SARS-CoV-2 IgM and IgG Antibodies 3 Months after COVID-19 Onset in Moroccan Patients
Assaid, N., Arich, S., Charoute, H., Akarid, K., Sadat, M. A., Maaroufi, A., Ezzikouri, S., & Sarih, M. (2022) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.22-0448 · Cited by 25
Liu, W., Kou, G., Dong, Y., Zheng, Y., Ding, Y., Ni, W., Wu, W., Tang, S., Xiong, Z., Zhang, Y., et al. (2020) · Journal of Clinical Virology · doi:10.1016/j.jcv.2020.104576 · Cited by 25
Self-citationDynamics of anti-SARS-CoV-2 IgG antibodies post-COVID-19 in a Brazilian Amazon population
Bichara, C. D. A., Amoras, E. D. S. G., Vaz, G. L., Torres, M. K. D. S., Queiroz, M. A. F., do Amaral, I. P. C., Vallinoto, I. M. V. C., Bichara, C. N. C., & Vallinoto, A. C. R. (2021) · BMC Infectious Diseases · doi:10.1186/s12879-021-06156-x · Cited by 26
Parai, D., Dash, G. C., Choudhary, H. R., Peter, A., Rout, U. K., Nanda, R. R., Kshatri, J. S., Kanungo, S., Pati, S., Turuk, J., et al. (2021) · Journal of Virological Methods · doi:10.1016/j.jviromet.2021.114121 · Cited by 25
Yuen, R. R., Steiner, D., Pihl, R. M. F., Chavez, E. C., Olson, A., Smith-Mahoney, E. L., Baird, L. A., Korkmaz, F. T., Urick, P., Sagar, M., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.614676 · Cited by 22
Coronaviruses pandemics: Can neutralizing antibodies help?
Tong, P. B. V., Lin, L., & Tran, T. H. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.117836 · Cited by 23
Infection Prevention Precautions for Routine Anesthesia Care During the SARS-CoV-2 Pandemic
Bowdle, A. T., Jelačić, S., Shishido, S., & Munoz-Price, L. S. (2020) · Anesthesia & Analgesia · doi:10.1213/ane.0000000000005169 · Cited by 28
Evaluation of three immunochromatographic tests for rapid detection of antibodies against SARS-CoV-2
Guedez-López, G. V., Alguacil-Guillén, M., González-Donapetry, P., Bloise, I., Tornero, C., González‐García, J., Mingorance, J., García‐Rodríguez, J., on behalf of the SARS-CoV-2 Working Group, Montero-Vega, M. D., et al. (2020) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-020-04010-7 · Cited by 24
Managing rheumatic diseases during COVID-19
Ladani, A. P., Loganathan, M. A., & Danve, A. S. (2020) · Clinical Rheumatology · doi:10.1007/s10067-020-05387-8 · Cited by 24
Zaichuk, T. A., Nechipurenko, Y. D., Adzhubey, A. A., Оникиенко, С. Б., Черешнев, В. А., Zainutdinov, S. S., Kochneva, G. V., Sv, N., & Matveeva, O. V. (2020) · Molecular Biology · doi:10.1134/s0026893320060151 · Cited by 25
(2020) · PubMed Central · doi:10.1002/bjs.12020 · Cited by 24
Zhang, X., Li, M., Zhang, B., Chen, T., Lv, D., Xia, P., Sun, Z., Shentu, X., Chen, H., Li, L., et al. (2020) · Clinica Chimica Acta · doi:10.1016/j.cca.2020.10.019 · Cited by 24
Favresse, J., Cadrobbi, J., Eucher, C., Elsen, M., Laffineur, K., Dogné, J., & Douxfils, J. (2020) · Journal of Medical Virology · doi:10.1002/jmv.26669 · Cited by 23
CRISPR-based biosensing systems: a way to rapidly diagnose COVID-19
Vatankhah, M., Azizi, A., Langeroudi, A. S., Azimi, S. A., Khorsand, I., Kerachian, M. A., & Motaei, J. (2020) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/10408363.2020.1849010 · Cited by 24
Fujita, K., Kada, S., Kanai, O., Hata, H., Odagaki, T., Satoh‐Asahara, N., Tagami, T., & Yasoda, A. (2020) · Frontiers in Public Health · doi:10.3389/fpubh.2020.595348 · Cited by 24
Palit, P., Mukhopadhyay, A., & Chattopadhyay, D. (2021) · Phytotherapy Research · doi:10.1002/ptr.7084 · Cited by 24
Lewin, A., Therrien, R., Serres, G. D., Grégoire, Y., Perreault, J., Drouin, M., Fournier, M., Tremblay, T., Beaudoin, J., Beaudoin-Bussières, G., et al. (2021) · Canadian Journal of Public Health · doi:10.17269/s41997-021-00531-6 · Cited by 23
Significance of SARS-CoV-2 specific antibody testing during COVID-19 vaccine allocation
Fujimoto, A. B., Keskinocak, P., & Yildirim, I. B. (2021) · Vaccine · doi:10.1016/j.vaccine.2021.06.067 · Cited by 24
Yadav, A. K., Ghosh, S., Kotwal, A., Kaushik, S. K., Bobdey, S., Sahu, R., Kapoor, S., Faujdar, D. S., Teli, P. T., & Anand, V. R. (2021) · Medical Journal Armed Forces India · doi:10.1016/j.mjafi.2021.06.007 · Cited by 26
Çolak, Ç. Y. (2021) · International Journal of Peptide Research and Therapeutics · doi:10.1007/s10989-021-10279-9 · Cited by 24
Elevated Anti-SARS-CoV-2 Antibodies and IL-6, IL-8, MIP-1β, Early Predictors of Severe COVID-19
Codina, H. C., Viéitez, I., Gutiérrez‐Valencia, A., Skouridou, V., Martínez, C., Patiño, L., Botero-Gallego, M., Trujillo‐Rodríguez, M., Serna‐Gallego, A., Muñoz‐Muela, E., et al. (2021) · Microorganisms · doi:10.3390/microorganisms9112259 · Cited by 27
Myeloid-derived suppressor cells in COVID-19: A review
Perfilyeva, Y. V., Ostapchuk, Y. O., Tleulieva, R., Kali, A., Abdolla, N., Krasnoshtanov, V. K., Perfilyeva, A. V., & Belyaev, N. N. (2022) · Clinical Immunology · doi:10.1016/j.clim.2022.109024 · Cited by 26
SARS-CoV-2 immunity and vaccine strategies in people with HIV
Mullender, C., da Costa, K., Alrubayyi, A., Pett, S. L., & Peppa, D. (2022) · Oxford Open Immunology · doi:10.1093/oxfimm/iqac005 · Cited by 23
Recent Infection With HCoV-OC43 Is Associated With Protection Against Sars-Cov-2 Infection
Lavell, A. H. A., Sikkens, J. J., Edridge, A. W. D., van der Straten, K., Sechan, F., Oomen, M., Buis, D. T. P., Schinkel, M., Burger, J. A., Poniman, M., et al. (2022) · iScience · doi:10.1016/j.isci.2022.105105 · Cited by 25
Good IgA Bad IgG in SARS-CoV-2 Infection?
Béné, M. C., Bittencourt, M. D. C., Eveillard, M., & Bris, Y. L. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa426 · Cited by 24
Norman, M., Gilboa, T., Ogata, A. F., Maley, A. M., Cohen, L., Cai, Y., Zhang, J., Feldman, J. E., Hauser, B. M., Caradonna, T. M., et al. (2020) · medRxiv · doi:10.1101/2020.04.28.20083691 · Cited by 25
Self-citationUwamino, Y., Kurafuji, T., Takato, K., Sakai, A., Tanabe, A., Noguchi, M., Yatabe, Y., Arai, T., Ohno, A., Tomita, Y., et al. (2022) · Vaccine · doi:10.1016/j.vaccine.2022.06.016 · Cited by 21
Dong, C., Li, F., Sun, Y., Long, D., Chen, C., Li, M., Wei, T., Martins, R. P., Chen, T., & Mak, P. (2023) · Lab on a Chip · doi:10.1039/d3lc00728f · Cited by 23
COVID-19 paraclinical diagnostic tools: Updates and future trends
Alsuliman, T., Sulaiman, R., Ismail, S., Srour, M., & Alrstom, A. (2020) · Current Research in Translational Medicine · doi:10.1016/j.retram.2020.06.001 · Cited by 22
Performance of an automated chemiluminescence SARS-CoV-2 IG-G assay
Lau, C. S., Oh, H. M., Hoo, S. P., Liang, Y.-L., Phua, S. K., & Aw, T. C. (2020) · Clinica Chimica Acta · doi:10.1016/j.cca.2020.09.005 · Cited by 23
Severe acute respiratory syndrome coronavirus‐2: implications for blood safety and sufficiency
Kiely, P., Hoad, V. C., Seed, C. R., & Gosbell, I. B. (2020) · Vox Sanguinis · doi:10.1111/vox.13009 · Cited by 24
Comparison of the clinical performance and usefulness of five SARS-CoV-2 antibody tests
Wakita, M., Idei, M., Saito, K., Horiuchi, Y., Yamatani, K., Ishikawa, S., Yamamoto, T. S., Igawa, G., Hinata, M., Kadota, K., et al. (2021) · PLoS ONE · doi:10.1371/journal.pone.0246536 · Cited by 23
Longitudinal SARS-CoV-2 antibody study using the Easy Check COVID-19 IgM/IgG™ lateral flow assay
Higgins, R. L., Rawlings, S. A., Case, J., Lee, F., Chan, C. W., Barrick, B. L., Burger, Z. C., Yeo, K.-T. J., & Marrinucci, D. C. (2021) · PLoS ONE · doi:10.1371/journal.pone.0247797 · Cited by 24
Santiago, L., Uranga-Murillo, I., Arias, M. A., González‐Ramírez, A. M., Macías‐León, J., Moreo, E., Redrado, S., García‐García, A., Taleb, V., Lira‐Navarrete, E., et al. (2021) · Biology · doi:10.3390/biology10030208 · Cited by 23
Determinants of IgG antibodies kinetics after severe and critical COVID‐19
Greef, J. D., Scohy, A., Zech, F., Nana, F. A., Pilette, C., Gérard, L., Pothen, L., Yıldız, H., Belkhir, L., & Yombi, J. C. (2021) · Journal of Medical Virology · doi:10.1002/jmv.27059 · Cited by 22
Mass SARS-CoV-2 serological screening, a population-based study in the Principality of Andorra
Royo, C., Vilanova, D., Lopez, J., Arroyo, V., Pons, M., Francisco, G., Carrasco, M. G., Piqué, J. M., Sanz, S., Dobaño, C., et al. (2021) · The Lancet Regional Health - Europe · doi:10.1016/j.lanepe.2021.100119 · Cited by 21
One-Stop Serum Assay Identifies COVID-19 Disease Severity and Vaccination Responses
Haddad, N. S., Nguyen, D. C., Kuruvilla, M. E., Morrison-Porter, A., Anam, F. A., Cashman, K. S., Ramonell, R. P., Kyu, S. Y., Saini, A. S., Cabrera-Mora, M., et al. (2021) · ImmunoHorizons · doi:10.4049/immunohorizons.2100011 · Cited by 29
Bondugula, R. K., Udgata, S. K., & Bommi, N. S. (2021) · Arabian Journal for Science and Engineering · doi:10.1007/s13369-021-05879-y · Cited by 25
Guo, Y., Li, T., Xia, X., Su, B., Li, H., Feng, Y., Han, J., Wang, X., Jia, L., Bao, Z., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.723585 · Cited by 21
Self-citationSARS-CoV-2 infection and disease outcomes in non-human primate models: advances and implications
Yuan, L., Tang, Q., Zhu, H., Guan, Y., Cheng, T., & Xia, N. (2021) · Emerging Microbes & Infections · doi:10.1080/22221751.2021.1976598 · Cited by 20
Self-citationAllen, N., Brady, M., Martín, A. I. C., Domegan, L. M., Walsh, C., Houlihan, E., Kerr, C., Doherty, L., King, J., Doheny, M., et al. (2021) · Microbiology Spectrum · doi:10.1128/spectrum.00391-21 · Cited by 24
Walle, I. V., Leitmeyer, K. C., Broberg, E., & the European COVID-19 microbiological laboratories group (2021) · Eurosurveillance · doi:10.2807/1560-7917.es.2021.26.45.2001675 · Cited by 23
Metadata
- Authors
- Zhao, J., Yuan, Q., Wang, H., Liu, W., Liao, X., Su, Y., Wang, X., Yuan, J., Li, T., Li, J., Qian, S., Hong, C., Wang, F., Liu, Y., Wang, Z., He, Q., Li, Z., He, B., Zhang, T., Fu, Y., Ge, S., Liu, L., Zhang, J., Xia, N., & Zhang, Z.
- Affiliations
- Shenzhen Third People’s Hospital (CN)
- Xiamen University (CN)
- Southern University of Science and Technology (CN)
- Corresponding author
- Zhang, Zheng
- ORCID
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2020-05-28
- Volume
- 71
- Issue
- 16
- Pages
- 2027-2034
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- PMC
- PMC7184337
- OpenAlex
- W3013985547
- Cited by
- 2,607
- References
- 13
- Citations by year
- 2026: 14 · 2025: 54 · 2024: 95 · 2023: 175 · 2022: 359 · 2021: 862 · 2020: 1046
- FWCI
- 80.11
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model (vor)
- Locations
- Clinical Infectious Diseases (publishedVersion)
- medRxiv (acceptedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Bill and Melinda Gates Foundation
- Topics
- Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
- Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 detection and testing
- Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
- Keywords
- SARS-CoV-2, COVID-19 pandemic, antibody response, seroconversion, IgM, IgG, serological diagnosis, viral RNA detection, disease severity, antibody titers, diagnostic sensitivity
- MeSH terms
- COVID-19, SARS-CoV-2, Adult, Aged, Antibodies, Viral, Antibody Formation, Enzyme-Linked Immunosorbent Assay, Female, Humans, Immunoglobulin G, Immunoglobulin M, Male, Middle Aged, Serologic Tests, Pandemics
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
